Works - 63964-2019

11/02/2019    S29    - - Works - Contract notice - Competitive dialogue 

United Kingdom-Sutton: Real estate services

2019/S 029-063964

Contract notice

Works

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
London Borough of Sutton
Civic Offices, St Nicholas Way
Sutton
SM1 1EA
United Kingdom
Contact person: Mr Daniel Doris
Telephone: +44 2087704857
E-mail: opportunitysutton@sutton.gov.uk
NUTS code: UKI63

Internet address(es):

Main address: http://www.sutton.gov.uk

Address of the buyer profile: http://www.londoncancerhub.org

I.2)Information about joint procurement
I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://www.londontenders.org/
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://www.londontenders.org/
I.4)Type of the contracting authority
Regional or local authority
I.5)Main activity
General public services

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Development Partner for The London Cancer Hub

Reference number: DN376438
II.1.2)Main CPV code
70000000
II.1.3)Type of contract
Works
II.1.4)Short description:

The London Borough of Sutton (LBS) is seeking a development partner, with experience in delivering high quality commercially led research and development and life science accommodation, that it can work with over the long term to deliver the vision of The London Cancer Hub.

The ambition is to create a world-leading cancer innovation centre on the Site, drawing on the pedigree of the adjacent ICR and The Royal Marsden. It will provide opportunities for scientists, clinicians, and innovative companies to come together in a world-class community built on the life science campus.

For further information, please visit: http://engage-emea.jll.com/london-cancer-hub

The Selection Questionnaire may be accessed via https://www.londontenders.org

II.1.5)Estimated total value
Value excluding VAT: 350 000 000.00 GBP
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)
45000000
45100000
45111000
45211350
45213000
45213100
45214600
45214610
45214620
45215100
45215140
66100000
70110000
70112000
71000000
71200000
71240000
71242000
71410000
73220000
II.2.3)Place of performance
NUTS code: UKI63
II.2.4)Description of the procurement:

Located strategically within the UK’s life science cluster known as the “Golden Triangle”, the London Cancer Campus, referred to as the Campus, in South West London extends to 21 hectares and includes land owned by The Institute of Cancer Research (ICR) and The Royal Marsden. As part of the Campus, LBS has acquired freehold title to 4,8 hectares of land. This is referred to as “the Site” and represents the commercial opportunity for a development partner. The site has the potential to accommodate up to 100 000 m2 of space and will enable private enterprises to locate within the Campus, furthering collaboration with the internationally renowned institutional anchors.

General areas of responsibility expected to be undertaken by the development partner include, but are not limited to:

— long term commitment to the London Cancer Hub vision,

— undertaking masterplanning, design and planning activity,

— raising of development finance,

— procurement of third party Contractors and supply chain management, and

— marketing and attraction of occupiers.

For further information, please visit: http://engage-emea.jll.com/london-cancer-hub

The Selection Questionnaire may be accessed via https://www.londontenders.org

II.2.5)Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value
Value excluding VAT: 350 000 000.00 GBP
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 240
This contract is subject to renewal: no
II.2.9)Information about the limits on the number of candidates to be invited
Envisaged minimum number: 3
Maximum number: 5
II.2.10)Information about variants
Variants will be accepted: yes
II.2.11)Information about options
Options: yes
Description of options:

There will be an option to renew after year 20 for a further 5 (five) years.

II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

Please refer to the Selection Questionnaire.

III.1.2)Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3)Technical and professional ability
Selection criteria as stated in the procurement documents
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:

Tenders will be opened through the e-portal within an hour of the time specified in the Selection Questionnaire.

No tender received after the time and date specified in the Selection Questionnaire will be considered without the express authority of LBS's Strategic Director of Resources.

Tender opening will be carried out by a representative nominated from LBS's Corporate Procurement Unit at the time of uploading the tender onto the portal.

III.2.3)Information about staff responsible for the performance of the contract
Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Competitive dialogue
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
Recourse to staged procedure to gradually reduce the number of solutions to be discussed or tenders to be negotiated
IV.1.6)Information about electronic auction
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
Notice number in the OJ S: 2018/S 238-542788
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 11/03/2019
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
Date: 23/04/2019
IV.2.4)Languages in which tenders or requests to participate may be submitted:
English
IV.2.6)Minimum time frame during which the tenderer must maintain the tender
IV.2.7)Conditions for opening of tenders

Section VI: Complementary information

VI.1)Information about recurrence
This is a recurrent procurement: no
VI.2)Information about electronic workflows
VI.3)Additional information:

Bidders must submit bids based on both:

Option A: (non-variant bid), delivery of the first phase building, either speculatively or on a market pre-let/pre-sale, and later phases; and

Option B: (mandatory variant) which shall include delivery of the first phase building on an income strip model with the PSDP as development manager with LBS taking the pre-let and option to buy back the freehold for a nominal sum.

The nature of the Legal Arrangement between LBS and PSDP will depend on what represents the most appropriate legal solution for the Project: either an incorporated joint venture vehicle or an unincorporated contractual arrangement (e.g. development agreement).

LBS may disclose identities of Applicants responding to the SQ to the Key Stakeholders, being: the Institute of Cancer Research, London, The Royal Marsden NHS Foundation Trust and Epsom St Helier University Hospitals NHS Trust.

One of the aims of the Project will be to operate in a spirit of mutual respect, trust and confidence and to give due regard to the Key Stakeholders' values, culture and normal business as leading providers of cancer research, education and training.

Marketing each phase of the Site must accord with the Lettings Policy (see e-portal).

Epsom St Helier University Hospitals NHS Trust may obtain development management services from the PSDP.

LBS may consider deploying the PSDP as its development manager for an alternative use if market conditions change.

The subject matter of the contract has been scoped to take into account LBS's priorities relating to economic, social and environmental well-being.

VI.4)Procedures for review
VI.4.1)Review body
High Court of England and Wales
Royal Courts of Justice, The Strand
London
WC1A 2LL
United Kingdom
VI.4.2)Body responsible for mediation procedures
High Court of England and Wales
Royal Courts of Justice, The Strand
London
WC1A 2LL
United Kingdom
VI.4.3)Review procedure
Precise information on deadline(s) for review procedures:

The Contracting Authority will observe a standstill period following the award of the contract and conduct itself in respect of any appeals in accordance with the Public Contracts Regulations 2015.

VI.4.4)Service from which information about the review procedure may be obtained
Cabinet Office
70 Whitehall
London
SW1A 2AS
United Kingdom
VI.5)Date of dispatch of this notice:
06/02/2019